Skip to Content
You are currently on the new version of our website. Access the old version .

Livers, Volume 2, Issue 4

2022 December - 13 articles

Cover Story: The production of reactive oxygen species (ROS) represents a critical event in liver physiology, and increasing evidence suggests that oxidative stress contributes to the development of liver diseases. Indeed, all chronic hepatic disorders share, as a common feature, a highly oxidative environment that perpetuates cellular damage and contributes to the progression of liver steatosis, fibrosis, inflammation, and ultimately hepatic tumorigenesis. This review provides an overview of the sources as well as targets of ROS in several liver diseases and highlights the pivotal role of oxidative stress in the different types of cell death occurring in hepatic cells. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (13)

  • Review
  • Open Access
6 Citations
4,236 Views
11 Pages

Role of Pyroptosis in Acetaminophen-Induced Hepatotoxicity

  • Hartmut Jaeschke,
  • David S. Umbaugh and
  • Anup Ramachandran

13 December 2022

Acetaminophen (APAP) is a widely used pain reliever that can cause liver injury or liver failure in response to an overdose. Understanding the mechanisms of APAP-induced cell death is critical for identifying new therapeutic targets. In this respect...

  • Article
  • Open Access
3 Citations
2,972 Views
13 Pages

9 December 2022

Despite the high medical and socioeconomic burden of non-alcoholic fatty liver disease (NAFLD), treatments that could effectively reduce histological liver damage in this condition are lacking. As providing only qualitative data is a major limitation...

  • Article
  • Open Access
5 Citations
2,845 Views
12 Pages

Anti-Metastatic Activity of Tagitinin C from Tithonia diversifolia in a Xenograft Mouse Model of Hepatocellular Carcinoma

  • Chuan-Yi Lin,
  • May-Hua Liao,
  • Chi-Yu Yang,
  • Chao-Kai Chang,
  • Shih-Mei Hsu,
  • Chi-Long Juang and
  • Hsiao-Chuan Wen

1 December 2022

Sesquiterpenoid tagitinin C, present in Tithonia diversifolia leaves, has been known to have anti-hepatoma properties. Therefore, we investigated the anti-metastatic potential of tagitinin C in xenograft models of hepatocellular carcinoma (HCC). We i...

  • Article
  • Open Access
2 Citations
4,687 Views
13 Pages

Preclinical Experience of the Mayo Spheroid Reservoir Bioartificial Liver (SRBAL) in Management of Acute Liver Failure

  • Philipp Felgendreff,
  • Mohammad Tharwat,
  • Seyed M. Hosseiniasl,
  • Bruce P. Amiot,
  • Anna Minshew,
  • Anan A. Abu Rmilah,
  • Xiaoye Sun,
  • Dustin Duffy,
  • Walter K. Kremers and
  • Scott L. Nyberg

2 November 2022

The Spheroid Reservoir Bioartificial Liver (SRBAL) is an innovative treatment option for acute liver failure (ALF). This extracorporeal support device, which provides detoxification and other liver functions using high-density culture of porcine hepa...

  • Review
  • Open Access
9 Citations
6,980 Views
15 Pages

2 November 2022

Chronic liver diseases (CLDs) that lead to hepatic fibrosis, cirrhosis, and/or hepatocellular carcinoma (HCC) have become a major cause of illness and death worldwide. The main causative factors for CLDs are chronic viral infections, excessive alcoho...

  • Review
  • Open Access
1 Citations
2,910 Views
11 Pages

FYB2 Is a Potential Prognostic Biomarker for Hepatocellular Carcinoma

  • Yifan Qu,
  • Xiaozhong Shen,
  • Xinpei Yuan and
  • Bing Lu

2 November 2022

FYB2 (also known as C1orf168 or ARAP) is an adaptor protein involved in T-cell receptor (TCR)-mediated T-cell activation and adhesion. However, the correlation of FYB2 with prognosis and cancer needs further investigation. In this study, we analyzed...

  • Article
  • Open Access
4 Citations
2,591 Views
17 Pages

Synergistic Anti-Tumor Effect of Palmitoylcarnitine and Dasatinib in Liver Cancer

  • Ragini Singh,
  • Shuang Cheng,
  • Qinghua Zeng,
  • Santosh Kumar and
  • Carlos Marques

1 November 2022

Hepatocellular carcinoma (HCC) is the third major cause of cancer-related death worldwide and responds positively to tyrosine kinase inhibitors (TKIs). Dasatinib (Das) is an Src/Abl family kinase and has been successfully utilized in the treatment of...

  • Article
  • Open Access
2,821 Views
8 Pages

Breath Analysis in Children with Ketogenic Glycogen Storage Diseases

  • Mohammad Nasser Kabbany,
  • Praveen Kumar Conjeevaram Selvakumar,
  • Xiaozhen Han,
  • Xiaofeng Wang,
  • David Grove,
  • Adriano R. Tonelli,
  • Raed A. Dweik,
  • Laurie Minarich,
  • Kadakkal Radhakrishnan and
  • Naim Alkhouri

21 October 2022

(1) Background: The treatment goal of ketogenic glycogen storage diseases (GSDs) is appropriate control of hypoglycemia and other disturbances such as dyslipidemia. Monitoring and treatment of ketosis are known to improve outcomes. We used breath ana...

  • Review
  • Open Access
5 Citations
2,944 Views
21 Pages

18 October 2022

Patients with advanced hepatocellular carcinoma (HCC) have a very limited survival rate even after the recent inclusion of kinase inhibitors or immune checkpoint inhibitors in the therapeutic armamentarium. A significant problem with the current prop...

  • Feature Paper
  • Review
  • Open Access
79 Citations
18,703 Views
32 Pages

Role of Oxidative Stress in Liver Disorders

  • Laura Conde de la Rosa,
  • Leire Goicoechea,
  • Sandra Torres,
  • Carmen Garcia-Ruiz and
  • José C. Fernandez-Checa

14 October 2022

Oxygen is vital for life as it is required for many different enzymatic reactions involved in intermediate metabolism and xenobiotic biotransformation. Moreover, oxygen consumption in the electron transport chain of mitochondria is used to drive the...

  • Article
  • Open Access
10 Citations
8,666 Views
19 Pages

Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)

  • Adnan Khan,
  • Heather M. Ross,
  • Natalia Salinas Parra,
  • Sarah L. Chen,
  • Kashyap Chauhan,
  • Makala Wang,
  • Brian Yan,
  • John Magagna,
  • Jake Beiriger and
  • Dina Halegoua-DeMarzio
  • + 2 authors

9 October 2022

Non-alcoholic fatty liver disease (NAFLD) is a serious clinicopathological condition that is recognized as the most frequent chronic liver disease, affecting 14–30% of the world’s population. The prevalence of NAFLD has rapidly grown and...

  • Case Report
  • Open Access
4,417 Views
6 Pages

Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report

  • Ludovico Abenavoli,
  • Luigi Boccuto,
  • Alessandro Corea,
  • Marialuisa Gambardella,
  • Rocco Spagnuolo and
  • Francesco Luzza

9 October 2022

Alagille syndrome (ALGS) is a genetic-driven condition of chronic cholestasis, involving the intrahepatic bile ducts, heart, vessels, kidneys, skeletal tissues, eyes, and nervous system. Pathological mechanisms are still not defined. JAG1 and NOTCH2...

  • Feature Paper
  • Review
  • Open Access
14 Citations
5,896 Views
15 Pages

One Carbon Metabolism and S-Adenosylmethionine in Non-Alcoholic Fatty Liver Disease Pathogenesis and Subtypes

  • David Fernández-Ramos,
  • Fernando Lopitz-Otsoa,
  • Oscar Millet,
  • Cristina Alonso,
  • Shelly C. Lu and
  • José M. Mato

4 October 2022

One carbon metabolism (1CM) can be defined as the transfer of a carbon unit from one metabolite to another and its replenishment by different sources of labile methyl-group nutrients: primarily choline, methionine, betaine, and serine. This flow of c...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Livers - ISSN 2673-4389